Patient subgroup | EQ-5D change from baseline | SF-6D change from baseline |
---|---|---|
Patients who completed the trial and had no adverse events | 0.252 | 0.094 |
Patients who completed the trial and had >30% pain relief | 0.286 | 0.113 |
Patients with at least one AE | 0.157 | 0.049 |
Patients with an AE that lead to withdrawal | 0.073 | 0.005 |
Patients who discontinued therapy due to lack of efficacy | 0.032 | 0.006 |